SCHEMBL4058049

SCHEMBL4058049

Cn1c(C(=O)O)nc(-c2cc(Cl)ccc2Cl)c1-c1ccc(Cl)cc1

nearest known ligand 0.59

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 18/20 0.59
OPRL1 P41146 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5986301 0.90 CNR1 (0.72) CNR1OPRL1
SCHEMBL4085388 0.85 CNR1 (0.67) CNR1
SCHEMBL4427351 0.82 CNR1 (0.66) CNR1OPRL1
SCHEMBL674192 0.80 CNR1 (0.85) CNR1
SCHEMBL4074362 0.79 CNR1 (0.67) CNR1OPRL1
SCHEMBL1319993 0.75 CNR1 (1.00) CNR1OPRL1
SCHEMBL4076013 0.74 CNR1 (0.71) CNR1OPRL1
SCHEMBL4085521 0.74 CNR1 (0.61) CNR1OPRL1
SCHEMBL4082543 0.72 CNR1 (0.64) CNR1
SCHEMBL4078180 0.72 CNR1 (0.70) CNR1OPRL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2012775-A1 USE OF CBX CANNABINOID RECEPTOR MODULATORS AS POTASSIUM CHANNEL MODULATORS Solvay Pharmaceuticals GmbH (DE) 2009-01-14 EP claimed
WO-2007125049-A1 USE OF CBX CANNABINOID RECEPTOR MODULATORS AS POTASSIUM CHANNEL MODULATORS SOLVAY PHARMACEUTICALS GMBH (DE) 2007-11-08 WO claimed